Travere Therapeutics (TVTX) on Wednesday announced the pricing of its underwritten offering of $475M aggregate principal amount of 0.50% convertible senior notes due 2032. The sale of the notes is ...
ON Semiconductor Corporation (Nasdaq: ON) (“onsemi”) announced today the pricing of its private offering of $1.3 billion aggregate principal amount of 0% Convertible Senior Notes due 2031 (the “notes” ...
(“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer, subject to market conditions and other ...
Tempus AI, Inc. ("Tempus") (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...
In early May 2026, Ocugen reported Q1 2026 results showing revenue of US$1.53 million with a larger quarterly net loss of US$19.18 million, and completed a US$115 million private offering of 6.75% ...
Detailed price information for Propetro Holding Corp (PUMP-N) from The Globe and Mail including charting and trades.
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and rare diseases, today ...
Tempus AI, Inc. (“Tempus”) (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced its intent to offer, subject to market ...
Bigger funding plan: Tempus AI increased its convertible notes sale from $350M to $400M, with a $60M option. Proceeds strategy: Funds will repay $307.7M in loans, cover capped call costs, and support ...
ProPetro Holding (NYSE:PUMP) shares fell 6% Monday after the company announced plans to offer $500 million in convertible senior notes due 2031 in a private place ...
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes
$1.0 billion offering of 0.25% convertible senior notes due 2032 $1.0 billion offering of 1.00% convertible senior notes due 2033 $300 million greenshoe fully exercised Capped call transactions ...
- Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 Convertible Notes prior to or at maturity CARLSBAD, Calif.--(BUSINESS WIRE)-- Ionis Pharmaceuticals, Inc. (IONS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results